Recursion Pharmaceuticals Shares Rise After Hours - Goldman Sachs Group (NYSE:GS), Morgan Stanley (NYSE:M
Recursion Pharmaceuticals Shares Rise After Hours - Goldman Sachs Group (NYSE:GS), Morgan Stanley (NYSE:M Benzinga
Covered in this story
Analyst targets on Goldman Sachs
- Citi: $879 → $1k by Oct 2027 · Neutral via MarketBeat
- TD Cowen: $895 → $1.05k by Oct 2027 · Buy via MarketBeat
- UBS: $893 → $1.01k by Oct 2027 · neutral via marketbeat.com
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $GS yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Goldman Sachs →Dalsna Finance is currently tracking 47 stories mentioning Goldman Sachs, the earliest published 8 Jun 2026.
Summary aggregated from Benzinga's public RSS feed. The full reporting belongs to Benzinga — please read it on their site.